In 2023, Parkinson's disease mortality in Canada was at 13.0 units per hundred thousand men, standardized rates. The forecast for 2024 is 13.1, following an upward trend. Year-on-year variations are modest but consistent: an increase of 0.8% from 2024 to 2025, 1.5% from 2025 to 2026, and 0.7% from 2026 to 2027, culminating in a 1.5% increase by 2028 compared to the previous year. Over the five-year period (2024-2028), the compound annual growth rate (CAGR) suggests an average annual increase of about 1.1%.
Future trends to watch for:
- Advancements in medical research and treatment options.
- Increased healthcare access which could impact mortality rates.
- Demographic shifts including aging population effects.
